Comparing Fesoterodine vs Solifenacin
| Fesoterodine | Solifenacin |
|
|---|
| Fesoterodine | Solifenacin |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Urinary Incontinence, Overactive Bladder, Urinary Frequency. Fesoterodine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Overactive Bladder, Urinary Incontinence, Urinary Frequency, Neurogenic Bladder, Neurogenic Detrusor Overactivity. Solifenacin may also be used for purposes not listed in this medication guide. View more |
Related suggestions Urinary Frequency
Urinary Incontinence
Overactive Bladder
|
|||||||
| More about Fesoterodine | More about Solifenacin | ||||||||
| Ratings & Reviews | |||||||||
|
Fesoterodine has an average rating of 5.3 out of 10 from a total of 77 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 36% reported a negative effect. |
Solifenacin has an average rating of 5.5 out of 10 from a total of 207 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Fesoterodine side effects |
View all Solifenacin side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Solifenacin prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Toviaz | VESIcare, VESIcare LS | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
7 hours |
68 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 321 drugs are known to interact with Fesoterodine:
|
A total of 497 drugs are known to interact with Solifenacin:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
October 31, 2008 |
November 19, 2004 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Myrbetriq
Myrbetriq (mirabegron) is used to treat overactive bladder with symptoms of frequent or urgent ...
Gemtesa
Gemtesa (vibegron) is used to treat overactive bladder symptoms (OAB) in adults or men taking ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
Detrol
Detrol is used to treat overactive bladder symptoms of urinary frequency, urgency, and ...
VESIcare
Vesicare is used to treat symptoms of overactive bladder such as incontinence and frequent ...
Ditropan
Ditropan XL (oxybutynin extended release) is used to treat the symptoms of overactive bladder ...
Estradiol Patch
Estradiol Patch is used for atrophic urethritis, atrophic vaginitis, breast cancer, palliative ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.